RHJA
VRNA
Rice Hall James & Associates’s Verona Pharma VRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.5M | Sell |
607,996
-215,016
| -26% | -$20.3M | 3.1% | 2 |
|
|
2025
Q1 | $52.3M | Sell |
823,012
-131,604
| -14% | -$8.36M | 3.07% | 2 |
|
|
2024
Q4 | $44.3M | Sell |
954,616
-30,460
| -3% | -$1.41M | 2.43% | 6 |
|
|
2024
Q3 | $28.3M | Buy |
985,076
+45,500
| +5% | +$1.31M | 1.53% | 16 |
|
|
2024
Q2 | $13.6M | Buy |
939,576
+263,819
| +39% | +$3.81M | 0.82% | 31 |
|
|
2024
Q1 | $10.9M | Buy |
675,757
+206,828
| +44% | +$3.33M | 0.62% | 47 |
|
|
2023
Q4 | $9.32M | Buy |
468,929
+443,055
| +1,712% | +$8.81M | 0.54% | 49 |
|
|
2023
Q3 | $422K | Buy |
+25,874
| New | +$422K | 0.03% | 246 |
|